SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Joe Louis — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJoe Louis
Date of birth1914-05-13
IdentifiersMRN HR-BX002-SYN-TD; SSN (made up) 000-02-6639
Document date1969-08-10
AuthorDesmond Achterberg-Cole, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week review: psychotic symptoms, urine tests and blood pressure. [S]

History of Present Illness

Mr. Louis returns four weeks after intake. About five days ago he noticed that he no longer believed he was being followed, and he now calls those fears part of the cocaine. He sleeps six to seven hours. In the first week of aripiprazole he felt a little restless in the evenings, which passed. All six contingency management urine tests have been negative, and he has drawn several prizes. He has had three therapy sessions and is working on what he does in the evenings and when he travels. His cold from the sick visit cleared within a week without a decongestant. His home blood pressure readings over the past week average 144/90. He met the social worker. He has signed a release allowing the clinic to talk with one family member he chose about his plan; no conversation has taken place yet. [S]

ElementDetail
CocaineNone for four weeks; six of six urine tests negative
Psychotic symptomsResolved about five days ago; insight full
AripiprazoleMild evening restlessness in the first week only
Home blood pressureAverage 144/90 mmHg over seven days
MoodPHQ-9 4; GAD-7 5

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy better; sleeping six to seven hours
CardiovascularNegativeNo chest pain, palpitations or breathlessness
NeurologicalNegativeNo restlessness now; no tremor
PsychiatricNegativeNo persecutory beliefs or hallucinations; no thoughts of suicide or of harming anyone

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives withOne spray as needed for suspected overdose; repeat in 2 to 3 minutes if neededNasal route1969-07-13activeS
Aripiprazole 5 mg oral tablet, one tablet each morningOne tablet each morningOral route1969-07-20 to 1969-09-21completedS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route1969-08-10activeS
Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestionTwo sprays in each nostril up to every 4 hours as neededNasal route1969-08-03 to 1969-08-08completedS
Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for sore throat or aches, no more than 3,000 mg a dayOne or two tablets every 6 hours as needed, no more than 3,000 mg a dayOral route1969-08-03 to 1969-08-08completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1969-08-10Body height187cmS
1969-08-10Body weight101.8kgS
1969-08-10Body mass index (BMI) [Ratio]29.1kg/m2S
1969-08-10Systolic blood pressure146mm[Hg]S
1969-08-10Diastolic blood pressure92mm[Hg]S
1969-08-10Heart rate82/minS
1969-08-10Respiratory rate16/minS
1969-08-10Body temperature36.7CelS
1969-08-10Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1969-08-10Albumin/Creatinine [Mass Ratio] in Urine14mg/g{creat}<=29 mg/g{creat}NormalS
1969-08-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1969-08-10Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S

Physical Exam

Vital signs recorded on 1969-08-10; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 146/92, pulse 82; weight 101.8 kg, BMI 29.1
CardiovascularRegular rhythm; no murmur; no carotid bruits
NeurologicalNo tremor or rigidity; no akathisia on observation; AIMS 0
PsychiatricRelaxed, warm and humorous; no delusional content; insight full

Problems

ProblemClinical statusVerificationCodeProvenance
Persecutory thoughts and poor sleep for about two months: a fixed belief that people are following him and plan to harm him, three to four hours of sleep a night, partial insight; cause under evaluationresolvedconfirmed R41.89S — Synthetic presenting problem anchored to his documented fears of a plot against his life; resolved into the diagnosis at the consultation. Not a claim about his real symptoms.
Cocaine use disorder, severe (seven of eleven DSM-5-TR criteria): intranasal cocaine most days for about a year, last use three days before intakeresolvedconfirmed F14.20S — Synthetic modern coding at intake; superseded at the consultation by the combined code once the psychotic disorder was diagnosed. Person-first language; not a claim about his real diagnosis.
Cocaine use disorder, severe, with cocaine-induced psychotic disorder (persecutory delusions during heavy use, persisting ten days after the last use, with no history of psychosis off cocaine, a normal examination and no evidence of a neurocognitive disorder); psychotic symptoms resolved within four weeks on aripiprazoleactiveconfirmed F14.250S — Synthetic modern diagnosis made at the consultation. Not a claim about his real diagnosis.
Raised blood pressure at intake (154/98 mmHg) three days after cocaine use, without a diagnosis of hypertension; home readings plannedresolvedconfirmed R03.0S — Synthetic presenting finding; resolved into a diagnosis of hypertension at four weeks.
Hypertension, stage 2, confirmed four weeks after the last cocaine use (clinic 146/92, home average 144/90 mmHg), with mild concentric left ventricular hypertrophy and a normal aortic root on echocardiography; treated with amlodipineactiveconfirmed I10S — Synthetic modern diagnosis made at the four-week visit.
Financial insecurity: years of tax debt from his time as a well-paid athlete, now settled, left him with no savings; irregular income from paid appearances; worry about money keeps him awakeactiveconfirmed Z59.86S — Synthetic social need anchored to his documented tax debt.
Acute viral upper respiratory infection (common cold) for three days; rapid tests negative for influenza and COVID-19; resolved within ten days without antibioticsresolvedconfirmed J06.9S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementCocaine use since the last visit (his own account), cravings and triggersEvery visitCompleted todayNo cocaine for four weeks; cravings less often
LaboratoryUrine drug tests in contingency management, with fentanyl, and prize draws for negative resultsTwice weekly for twelve weeks, then at visitsCompleted todaySix of six tests negative for cocaine and fentanyl; prizes drawn
ExaminationPsychotic symptoms, insight and sleepEvery visitCompleted todayNo persecutory beliefs for about five days; insight full; sleeping six to seven hours
Medication safetyAntipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS)Weight and akathisia at every visit while on treatment; AIMS at baseline and every six monthsCompleted todayWeight 101.8 kg, up 0.8 kg; mild restlessness in the first week, now gone; no akathisia; AIMS 0
LaboratoryFasting glucose or hemoglobin A1c and lipids on an antipsychoticBaseline, at four months, then yearlyUp to dateBaseline done; next at four months if he is still on aripiprazole
ExaminationCognitive screen (MoCA)At baseline and again once he is well and off cocaineDueRepeat at the ten-week visit, after a longer time well
ExaminationBlood pressure in clinic and at homeEvery visit; home readings before diagnosis and after each changeCompleted todayClinic 146/92; home average 144/90 mmHg; stage 2 hypertension; amlodipine started
LaboratoryUrine albumin-to-creatinine ratio, creatinine and potassium at diagnosis of hypertensionAt diagnosis, then yearlyCompleted todayUrine albumin-to-creatinine ratio 14 mg/g; creatinine 1.16 mg/dL, eGFR 74 and potassium 4.1 mmol/L at intake
ImagingEchocardiogram for stage 2 hypertension or left ventricular hypertrophyAt diagnosisOrderedBooked for the morning of the ten-week visit
SurveySuicide and violence risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or of harming anyone; 988 in his phone
Medication safetyNaloxone and fentanyl test strips on handEvery visitCompleted todayNaloxone and test strips still at home
SurveyDepression (PHQ-9) and anxiety (GAD-7)At baseline and every four weeks while in treatmentCompleted todayPHQ-9 4, item 9 scored 0; GAD-7 5
Self-managementCognitive behavioral therapyWeeklyCompleted todayThree sessions attended
Self-managementFinances, social work and taxpayer servicesEvery visitReferredBudget made with the social worker; Low Income Taxpayer Clinic appointment next month
Self-managementFamily involvement, only with his consentEvery visitCompleted todayHe signed a release for one family member he chose; no contact yet

Goal progress:

Guideline basis: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020); Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026)

Follow-up: Preventive visit in five weeks. Ten-week review in six weeks with the echocardiogram that morning and the MoCA. Home readings daily for two weeks, then twice a week. Next scheduled visit 1969-09-14: periodic adult preventive visit. [S]